Smith & Nephew Plc Director/PDMR Shareholding
23 May 2024 - 1:23AM
RNS Regulatory News
RNS Number : 5239P
Smith & Nephew Plc
22 May 2024
SMITH & NEPHEW PLC
22
May 2024
NOTIFICATION AND PUBLIC DISCLOSURE
IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE
REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH
THEM.
1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE
PLAN 2020
On 20 and 21 May 2024, the Company
received notification of the following transactions in US$0.20
ordinary shares (the "Shares") in Smith & Nephew plc (the
"Company") following the vesting of awards under the Smith &
Nephew Global Share Plan 2020.
All figures in these columns are
stated to 6 decimal places where applicable.
i. FINAL VESTING OF 2021 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE
PLAN 2020:
The awards were granted under the
Global Share Plan 2020 on 21 May 2021. One third of the Shares
vested on 21 May 2022, a further third vested on 21 May 2023 and
the final third vested on 21 May 2024. A number of Shares were sold
to cover taxation obligations arising on the vesting of the
awards.
The following relates to individuals
included in the below notification:
|
Reason for the notification
|
|
Initial notification
/Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith &
Nephew plc ordinary shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Final vesting on 21 May 2024 of
Conditional Share awards granted on 21 May 2021 under the Smith
& Nephew Global Share Plan 2020, and subsequent sale of shares
to cover tax liability
|
|
Date of Transaction
|
2024 - 05 - 21
|
|
Place of Transaction
|
London Stock Exchange
(XLON)
|
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
|
Craig Gaffin
President, Global
Orthopaedics
|
PDMR
|
10.1175
|
1,522 (of which 372 were sold and
1,150 were retained.)
|
N/A Single Transaction
|
|
Scott Schaffner
(President Sports
Medicine)
|
PDMR
|
10.1175
|
1,141 (of which 279 were sold and
862 retained.)
|
N/A Single Transaction
|
ii. PARTIAL VESTING OF 2022
CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN
2020:
The awards were granted under the
Global Share Plan 2020 on 12 August 2022. One quarter of the Shares
vested on 20 May 2023, a further quarter vested on 20 May 2024 and
the final half will vest on 20 May 2025. A number of Shares were
sold to cover taxation obligations arising on the vesting of the
awards.
The following relates to individuals
included in the below notification:
|
Reason for the notification
|
|
Initial notification
/Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith &
Nephew plc ordinary shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Partial vesting on 20 May 2024 of
Conditional Share awards granted on 12 August 2022 under the Smith
& Nephew Global Share Plan 2020, and subsequent sale of shares
to cover tax liability
|
|
Date of Transaction
|
2024 - 05 - 20
|
|
Place of Transaction
|
London Stock Exchange
(XLON)
|
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
|
Elga Lohler
(Chief HR Officer)
|
PDMR
|
10.290135
|
10,088 (of which 4,010 were sold and
6,078 were retained.)
|
N/A Single Transaction
|
iii. PARTIAL VESTING OF 2023
CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN
2020:
The awards were granted under the
Global Share Plan 2020 on 19 May 2023. One quarter of the Shares
vested on 20 May 2024, a further quarter will vest on 19 May 2025
and the final half will vest on 19 May 2026. A number of Shares
were sold to cover taxation obligations arising on the vesting of
the awards.
The following relates to individuals
included in the below notification:
|
Reason for the notification
|
|
Initial notification
/Amendment
|
Initial notification
|
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
|
LEI
|
213800ZTMDN8S67S1H61
|
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith &
Nephew plc ordinary shares of USD 0.20 each
|
|
Identification code
|
ISIN: GB0009223206
|
|
Nature of the transaction
|
Partial vesting on 20 May 2024 of
Conditional Share awards granted on 19 May 2023 under the Smith
& Nephew Global Share Plan 2020, and subsequent sale of shares
to cover tax liability
|
|
Date of Transaction
|
2024 - 05 - 20
|
|
Place of Transaction
|
London Stock Exchange
(XLON)
|
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
|
Craig Gaffin
President, Global
Orthopaedics
|
PDMR
|
10.290135
|
1,551 (of which 379 were sold and
1,172 were retained.)
|
N/A Single Transaction
|
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923
477100
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHFLFFEELIFFIS
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From May 2024 to Jun 2024
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From Jun 2023 to Jun 2024
